https://www.chromacode.com/chromacodes-emergency-use-authorization-eua-expanded-by-fda-for-high-throughput-hdpcr-sars-cov-2-real-time-pcr-assay/ 2023-04-21T21:28:24+00:00 https://www.chromacode.com/chromacode-announces-partnership-with-medgenome-to-bring-hdpcr-based-diagnostics-to-india-and-the-middle-east/ 2023-04-27T17:05:55+00:00 https://www.chromacode.com/chromacode-and-protean-biodiagnostics-establish-strategic-partnership-to-introduce-a-hdpcr-based-nsclc-assay-in-the-u-s/ 2023-09-20T19:15:58+00:00 https://www.chromacode.com/chromacode-announces-commercial-availability-of-hdpcr-based-non-small-cell-lung-cancer-assay/ 2023-09-20T19:34:08+00:00 https://www.chromacode.com/chromacode-showcases-hdpcr-oncology-data-on-quantstudio-absolute-q-dpcr-system-at-the-amp-2022-annual-meeting/ 2023-10-02T15:13:41+00:00 https://www.chromacode.com/chromacode-announces-landmark-peer-reviewed-publication-on-breakthrough-hdpcr-assay-for-non-small-cell-lung-cancer/ 2023-10-06T04:54:52+00:00 https://www.chromacode.com/chromacode-to-show-new-data-in-oncology-and-blood-based-monitoring-at-the-association-for-molecular-pathology-2023-annual-meeting-and-expo/ 2023-11-01T16:15:27+00:00 https://www.chromacode.com/chromacode-announces-publication-highlighting-advancements-in-hdpcr-nsclc-assay-performance-demonstrating-advantages-over-next-generation-sequencing-in-enabling-timely-results-and-as-a-vital-rescue/ 2023-11-14T16:47:08+00:00 https://www.chromacode.com/chromacode-unveils-chromacode-cloud-6-1/ 2024-01-04T21:15:21+00:00 https://www.chromacode.com/chromacode-and-tennessee-oncology-sign-early-access-agreement/ 2024-01-08T20:37:31+00:00 https://www.chromacode.com/chromacode-announces-appointment-of-mark-mcdonough-as-chairman/ 2024-01-10T16:58:12+00:00 https://www.chromacode.com/chromacode-announces-publication-of-new-study-demonstrating-the-superior-performance-of-its-hdpcr-nsclc-assay-compared-to-ngs-with-low-sample-input/ 2024-01-26T23:54:37+00:00